The SRRSH Department of Head and Neck Surgery was founded in 1995 by Dr. GAO Li, a well-known professor in the country. The department currently has 22 doctors (all of whom have a doctorate or master's degree), including 2 chief physicians and 4 deputy chief physicians. It has 60 approved beds with more than 56,000 outpatient visits per year, and nearly 3,000 thyroid cancer surgeries performed per year. The department's workload has been at the forefront of the province for several consecutive years. The current department director is Dr. XIE Lei.

The department is the first to carry out minimally invasive lateral neck dissection, upper mediastinal dissection and parapharyngeal lymph node dissection in China, which avoids the damage to the appearance of the neck and thoracotomy. We routinely perform transoral thyroidectomy, modified gasless unilateral axillary approach endoscopic thyroid surgery, and thyroidectomy using the sub-clavian approach; surgery for locally advanced or recurrent thyroid cancer. In the aspect of intraoperative in situ preservation of parathyroid glands, the department pioneered the concept of "thymus-vascular-hypoparathyroid gland level", which has significantly reduced the incidence of postoperative hypoparathyroidism and has attracted the attention of domestic and foreign counterparts. We fully integrate preoperative B-ultrasound, B-ultrasound-guided fine needle aspiration and NGS for thyroid cancer to achieve a comprehensive and refined preoperative assessment of thyroid cancer. We routinely carry out endoscopic-assisted oral and maxillofacial tumor surgery and open reduction and internal fixation of oral and maxillofacial fractures.

Our team is committed to the minimally invasive and refined reconstruction of thyroid surgery, oral and maxillofacial tumors, and fracture surgery; the improvement of parathyroid in situ preservation or distant transplantation and further improvement of the preoperative individualization of thyroid cancer and refined evaluation; exploratory implementation, gradually evolved a simple patient data database into a clinical decision support system (CDSS) to provide a detailed basis for improving the quality of diagnosis and treatment. The department strives to create a dynamic observation system for low-risk micro papillary thyroid cancer. Excessive surgical treatment is avoided and patients can be scientifically examined and managed effectively during follow-up.

Thyroid Surgery

Our department provides refined and individualized preoperative evaluations of thyroid cancer; it has various minimally invasive surgical methods for thyroid cancer such as endoscopic-assisted transoral, transaxillary, supraclavicular, and anterior neck incisions. And according to the patient's individual situation to achieve personalized selection, we have the most complete post-operative follow-up review system for thyroid cancer in China, as well as a dynamic observation system for low-risk small papillary thyroid carcinomas

Oral and Maxillofacial Surgery

Endoscopic assisted minimally invasive and concealing incision submandibular gland and parotid gland surgery

Endoscopic-assisted small-incision maxillofacial fracture resection and internal fixation

Comprehensive treatment of oral cancer: targeted therapy for oral cancer, perioperative neoadjuvant chemotherapy, radical oral cancer surgery and metastatic flap repair.